Seeking Alpha

"The decline of the order intake was very disappointing," says analyst Jos Versteeg referring to...

"The decline of the order intake was very disappointing," says analyst Jos Versteeg referring to weakness in Philips' (PHG) healthcare unit which the company says should still experience 3-4% growth for the full year (Q1 results). When asked on the call how confident the company is about delivering on that prediction, CEO Frans van Houten says "more traction in Northern Europe" and "increased orders on the government side" in the U.S. make him absolutely confident in the healthcare unit's "resiliency" in the eurozone and positioning in the U.S. once "the dust settles" on healthcare reform. (transcript)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs